Ducheside A is primarily used in pharmaceutical research due to its bioactive properties. It exhibits anti-inflammatory and neuroprotective effects, making it a candidate for development in treatments for neurodegenerative conditions such as Alzheimer’s and Parkinson’s disease. Studies suggest it modulates key signaling pathways involved in oxidative stress and neuronal survival. It is also investigated for its potential in managing metabolic disorders, showing influence on glucose metabolism and insulin sensitivity in preclinical models. Its natural origin and low toxicity profile support its use in early-stage drug discovery and as a reference compound in pharmacological screening.